Navigation Links
Onyx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
Date:3/2/2011

EMERYVILLE, Calif., March 2, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Cowen and Company 31st Annual Health Care Conference on Wednesday, March 9, 2011 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time).  

Interested parties may access a live webcast of the presentation on our website at:

http://www.onyx-pharm.com/view.cfm/32/Event-Calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software.  For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through March 23, 2011.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals Inc., is developing and marketing Nexavar® (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. Beyond Nexavar, Onyx has established a development pipeline of anticancer compounds at various stages of clinical testing, including carfilzomib, a selective proteasome inhibitor, that is currently being evaluated in multiple clinical trials for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors. ONX 0801, an alpha-folate receptor targeted inhibitor of thymidylate synthase, and ONX 0912, an oral proteasome inhibitor, are currently in Phase 1 testing. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

Nexavar® (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Present at the 31st Annual Cowen & Co. Health Care Conference
2. Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.
3. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
4. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
5. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
6. N30 Pharmaceuticals to Present S-Nitrosoglutathione Reductase Inhibitor Preclinical Safety Data at 2011 Society of Toxicology 50th Anniversary Meeting
7. Lexicon Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
8. Anadys Pharmaceuticals to Present at the Cowen & Company Healthcare Conference
9. Access Pharmaceuticals to Host Update Conference Call for Investors
10. Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
11. Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results Conference Call on March 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... -- CANTEL MEDICAL CORP. (NYSE: CMD ) reported ... diluted share, on a 22.1% increase in sales to a ... This compares with net income of $14,254,000, or $0.34 per ... ended October 31, 2015. Non-GAAP net income ... to $21,323,000, or $0.51 per diluted share, compared with non-GAAP ...
(Date:12/8/2016)... 8, 2016   Mederi Therapeutics Inc . has announced regulatory approval by CFDA ... treatment for chronic gastroesophageal reflux disease (GERD). Continue ... ... the Chinese Congress of Digestive Endoscopy, by Professor Jun Liu, Director of Endoscopy at ... , "We are very pleased that Mederi ...
(Date:12/8/2016)... , and SAN DIEGO , Dec. ... services and solutions with cutting edge next-generation sequencing and bioinformatics ... biotechnology company; and the Genome Institute of Singapore ... – a new joint venture between Novogene and AITbiotech – ... Biopolis, Singapore .   The ...
Breaking Medicine Technology:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... financial consulting services to residential and commercial clients in the northern Alabama and ... for Nobis Works. , Since 1977, Nobis Works has built a network of ...
(Date:12/7/2016)... ... December 07, 2016 , ... Students attending ... the unique opportunity to get hands-on experience in an emergency medical simulation, When ... experience to gain invaluable, real-life medical skills that are critical success in a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to secondhand ... at the Icahn School of Medicine at Mount Sinai has found. The study ... young children are exposed to secondhand marijuana smoke, measurable amounts of primary metabolite ...
(Date:12/7/2016)... ... December 07, 2016 , ... OC87 ... with a schizophrenic mother in a unique, personal perspective through animation. , ... trauma and addictive disorders at her private psychotherapy practice. Sheri’s mother, Pearl, lived ...
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any ... useful, properly analyzed data. The team at Beckman Coulter has designed Kaluza, templates with ... speed' and the need to operate in a GLP (Good Laboratory Practice) fashion. , ...
Breaking Medicine News(10 mins):